Beacon Group has appointed Dr Rajesh Patel as its new Group Chief Executive Officer, effective April 1, 2026, in a move aimed at strengthening its leadership team and accelerating growth.
Dr Patel brings more than three decades of experience in the healthcare and diagnostics industry. Over his career, he has worked across key areas such as business development, sales, marketing, and strategic planning. He is widely recognised for driving operational improvements and expanding businesses within the diagnostics sector.
In his new role, Dr Patel will oversee operations across the group’s key entities, including Beacon Diagnostics, Vector Biotek, and Biogeny Diagnostics. His focus will be on aligning strategies across these companies, improving coordination, and ensuring efficient execution of business plans.
The company said Dr Patel will play a crucial role in shaping its long-term vision. His responsibilities include driving expansion into new markets, strengthening organisational capabilities, and enhancing overall service quality. He is also expected to lead efforts to build stronger relationships with customers and partners across the healthcare ecosystem.
Beacon Group is looking to expand its footprint in the in-vitro diagnostics (IVD) segment, a fast-growing area in India’s healthcare industry. The company aims to cater to a wide range of clients, including large laboratory chains, hospitals, and independent labs, while maintaining a strong focus on innovation and quality.
Welcoming the appointment, the company’s leadership expressed confidence that Dr Patel’s experience and strategic approach will help guide Beacon Group through its next phase of growth. His leadership is expected to support the company’s ambition of becoming a major player in the diagnostics market.
Also Read: Gautam Adani gets US Court hearing